Ausgabe 6/1998
Inhalt (21 Artikel)
Clinical evaluation of a commercial ligase-based gene amplification method for detection ofMycobacterium tuberculosis
P. Alonso, A. Orduña, M. A. Bratos, A. San Miguel, A. Rodríguez Torres
Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985–1996
M. Crowe, P. Ispahani, H. Humphreys, T. Kelley, R. Winter
Antibiotic resistance inSalmonella enterica serotype typhimurium
U. Groß, H. Tschäpe, I. Bednarek, M. Frosch
Comparison of three media for agar dilution susceptibility testing ofBordetella pertussis using six antibiotics
J. E. Hoppe, T. Paulus
Non-tuberculous mycobacterial infection in children with cancer
J. C. Graham, D. A. Tweddle, D. R. Jenkins, C. Pollitt, S. J. Pedler
In vitro activity of mupirocin against methicillin-resistantStaphylococcus aureus isolated from a hospital in Spain
T. Alarcón, D. Domingo, M. C. del Rey, S. López, I. Sánchez, M. López-Brea
Urinary tract infection due toArcanobacterium bernardiae in a patient with a urinary tract diversion
J. P. Lepargneur, R. Heller, R. Soulié, P. Riegel
Association between quinupristin/dalfopristin resistance in glycopeptide-resistantEnterococcus faecium and the use of additives in animal feed
G. Werner, I. Klare, W. Witte
Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens
J. -C. Pechère, T. D. Gootz
Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin
D. Pontani, H. Washton, S. Bouchillon, J. Johnson
A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental Legionellosis in guinea pigs
J. García-de-Lomas, E. Millás, M. A. Lázaro, M. Bermejo, C. Gimeno, D. Navarro, S. Sánchez
Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers
G. Melnik, W. H. Schwesinger, R. Teng, L. C. Dogolo, J. Vincent
Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans
J. Vincent, L. Dogolo, B. A. Baris, S. A. Willavize, R. Teng
An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin
L. Purkins, S. D. Oliver, S. A. Willavize
Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis
P. Léophonte, R. J. T. Baldwin, N. Pluck
Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia
F. Trémolières, F. de Kock, N. Pluck, R. Daniel
Safety of trovafloxacin in treatment of lower respiratory tract infections
D. Williams, S. Hopkins